BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24122263)

  • 1. Metastatic progression of breast cancer: insights from 50 years of autopsies.
    Cummings MC; Simpson PT; Reid LE; Jayanthan J; Skerman J; Song S; McCart Reed AE; Kutasovic JR; Morey AL; Marquart L; O'Rourke P; Lakhani SR
    J Pathol; 2014 Jan; 232(1):23-31. PubMed ID: 24122263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
    Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
    Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
    Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
    BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study.
    Kutasovic JR; McCart Reed AE; Males R; Sim S; Saunus JM; Dalley A; McEvoy CR; Dedina L; Miller G; Peyton S; Reid L; Lal S; Niland C; Ferguson K; Fellowes AP; Al-Ejeh F; Lakhani SR; Cummings MC; Simpson PT
    J Pathol Clin Res; 2019 Jan; 5(1):25-39. PubMed ID: 30246500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based Study.
    Kulka J; Székely B; Lukács LV; Kiss O; Tőkés AM; Vincze E; Turányi E; Fillinger J; Hanzély Z; Arató G; Szendrői M; Győrffy B; Szász AM
    J Histochem Cytochem; 2016 Apr; 64(4):256-67. PubMed ID: 27029768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific gene expression signature for visceral organ metastasis in breast cancer.
    Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
    BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.
    Lawler K; Papouli E; Naceur-Lombardelli C; Mera A; Ougham K; Tutt A; Kimbung S; Hedenfalk I; Zhan J; Zhang H; Buus R; Dowsett M; Ng T; Pinder SE; Parker P; Holmberg L; Gillett CE; Grigoriadis A; Purushotham A
    Breast Cancer Res; 2017 Oct; 19(1):113. PubMed ID: 29029636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone.
    Rhu J; Lee SK; Kil WH; Lee JE; Nam SJ
    ANZ J Surg; 2015 Apr; 85(4):240-4. PubMed ID: 25996008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.
    Sihto H; Lundin J; Lundin M; Lehtimäki T; Ristimäki A; Holli K; Sailas L; Kataja V; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Breast Cancer Res; 2011 Sep; 13(5):R87. PubMed ID: 21914172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.
    Razis E; Bobos M; Kotoula V; Eleftheraki AG; Kalofonos HP; Pavlakis K; Papakostas P; Aravantinos G; Rigakos G; Efstratiou I; Petraki K; Bafaloukos D; Kostopoulos I; Pectasides D; Kalogeras KT; Skarlos D; Fountzilas G
    Breast Cancer Res Treat; 2011 Jul; 128(2):447-56. PubMed ID: 21594665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of metastatic behaviour of breast cancer subtypes.
    Savci-Heijink CD; Halfwerk H; Hooijer GK; Horlings HM; Wesseling J; van de Vijver MJ
    Breast Cancer Res Treat; 2015 Apr; 150(3):547-57. PubMed ID: 25820592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.
    Singhi AD; Cimino-Mathews A; Jenkins RB; Lan F; Fink SR; Nassar H; Vang R; Fetting JH; Hicks J; Sukumar S; De Marzo AM; Argani P
    Mod Pathol; 2012 Mar; 25(3):378-87. PubMed ID: 22056952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.
    Harrell JC; Prat A; Parker JS; Fan C; He X; Carey L; Anders C; Ewend M; Perou CM
    Breast Cancer Res Treat; 2012 Apr; 132(2):523-35. PubMed ID: 21671017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
    Abdel-Rahman O
    Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
    Press DJ; Miller ME; Liederbach E; Yao K; Huo D
    Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.
    Hampl M; Hampl JA; Reiss G; Schackert G; Saeger HD; Schackert HK
    Clin Cancer Res; 1999 Jun; 5(6):1417-25. PubMed ID: 10389927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: an autopsy study of 25 patients.
    Szekely B; Nagy ZI; Farago Z; Kiss O; Lotz G; Kovacs KA; Madaras L; Udvarhelyi N; Dank M; Szentmartoni G; Baranyai Z; Harsanyi L; Tőkés AM; Timar J; Szasz AM; Kulka J
    Clin Exp Metastasis; 2017 Jan; 34(1):103-113. PubMed ID: 27885435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distant metastasis in triple-negative breast cancer.
    Tseng LM; Hsu NC; Chen SC; Lu YS; Lin CH; Chang DY; Li H; Lin YC; Chang HK; Chao TC; Ouyang F; Hou MF
    Neoplasma; 2013; 60(3):290-4. PubMed ID: 23373998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.